Joshua R. Disbrow - 03 Oct 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan J. Selhorn as attorney-in-fact for Joshua R. Disbrow
Issuer symbol
AYTU
Transactions as of
03 Oct 2025
Transactions value $
$0
Form type
4
Filing time
07 Oct 2025, 16:11:20
Previous filing
10 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Disbrow Joshua R. Chief Executive Officer, Director C/O AYTU BIOPHARMA, INC., 7900 EAST UNION AVENUE, SUITE 920, DENVER /s/ Ryan J. Selhorn as attorney-in-fact for Joshua R. Disbrow 07 Oct 2025 0001566240

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Stock Award $0 +31.4K +20.52% $0.00 185K 03 Oct 2025 Direct F1
transaction AYTU Common Stock Award $0 +22.5K +12.18% $0.00 207K 03 Oct 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus.
F2 Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.

Remarks:

Exhibit 24: Power of Attorney